Baillie Gifford & Co. Has $120.61 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Key Points

• Baillie Gifford & Co. increased its stake in CME Group Inc. by 14.5%, acquiring 57,699 shares, bringing its total ownership to 454,643 shares valued at approximately $120.6 million.
• Several institutional investors, including Caliber Wealth Management and Assetmark Inc., have also adjusted their positions in CME Group, which has an overall institutional ownership of 87.75%.
• CME Group recently reported a quarterly earnings per share of $2.96, exceeding estimates, along with a 10.4% increase in revenue compared to last year, and declared a quarterly dividend of $1.25.

Baillie Gifford & Co. raised its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 14.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 454,643 shares of the financial services provider's stock after buying an additional 57,699 shares during the period. Baillie Gifford & Co. owned approximately 0.13% of CME Group worth $120,612,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Caliber Wealth Management LLC KS acquired a new position in CME Group during the 1st quarter valued at about $3,761,000. Assetmark Inc. boosted its position in shares of CME Group by 4.2% during the 1st quarter. Assetmark Inc. now owns 25,081 shares of the financial services provider's stock valued at $6,654,000 after purchasing an additional 1,004 shares in the last quarter. Navellier & Associates Inc. bought a new position in shares of CME Group during the 1st quarter valued at about $3,045,000. Cetera Investment Advisers boosted its position in shares of CME Group by 18.7% during the 1st quarter. Cetera Investment Advisers now owns 40,196 shares of the financial services provider's stock valued at $10,664,000 after purchasing an additional 6,319 shares in the last quarter. Finally, Avantax Advisory Services Inc. boosted its position in shares of CME Group by 5.1% during the 1st quarter. Avantax Advisory Services Inc. now owns 19,431 shares of the financial services provider's stock valued at $5,155,000 after purchasing an additional 945 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Stock Up 1.1%

CME traded up $2.95 during midday trading on Wednesday, hitting $277.55. 341,120 shares of the company's stock traded hands, compared to its average volume of 2,367,977. The company has a market cap of $100.02 billion, a PE ratio of 26.89, a price-to-earnings-growth ratio of 4.87 and a beta of 0.44. The stock's fifty day simple moving average is $276.29 and its 200-day simple moving average is $263.11. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a one year low of $193.25 and a one year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the firm earned $2.56 earnings per share. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date was Monday, June 9th. CME Group's dividend payout ratio is 48.40%.

Insider Buying and Selling at CME Group

In related news, insider Derek Sammann sold 4,650 shares of the business's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider owned 8,336 shares of the company's stock, valued at approximately $2,339,164.96. The trade was a 35.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction on Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the sale, the director owned 3,108 shares in the company, valued at $863,651.04. This represents a 25.43% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 10,400 shares of company stock valued at $2,881,130 in the last three months. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Morgan Stanley raised their price objective on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Barclays set a $298.00 price objective on shares of CME Group and gave the company an "equal weight" rating in a research report on Thursday, July 24th. JPMorgan Chase & Co. reduced their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Royal Bank Of Canada reiterated a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a report on Thursday, April 3rd. Finally, Citigroup raised their target price on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, CME Group presently has an average rating of "Hold" and a consensus target price of $261.93.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.